Indiva Ltd NDVAF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.05
- Day Range
- $0.05–0.05
- 52-Week Range
- $0.01–0.09
- Bid/Ask
- $0.03 / $0.26
- Market Cap
- $9.46 Mil
- Volume/Avg
- 2,180 / 17,818
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.29
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Indiva Ltd sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, the company produces and distributes award-winning cannabis products nationally, including Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Sapphire Cannabis Salt, as well as capsules, pre-rolls and premium flower under the INDIVA and Artisan Batch brands.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 142
- Website
- https://www.indiva.com
Valuation
|
Metric
|
NDVAF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 33.04 |
Price/Sales | 0.29 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NDVAF
|
|---|---|
Quick Ratio | 0.58 |
Current Ratio | 0.85 |
Interest Coverage | −0.52 |
Quick Ratio
NDVAF
Profitability
|
Metric
|
NDVAF
|
|---|---|
Return on Assets (Normalized) | −15.40% |
Return on Equity (Normalized) | −356.26% |
Return on Invested Capital (Normalized) | −5.35% |
Return on Assets
NDVAF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Xgdppqpkbn | Zhvtbr | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Klsxxsyjc | Vkdw | $68.9 Bil | |
HLN
| Haleon PLC ADR | Lghsfmkx | Sxg | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Scnkqcsc | Cfmy | $14.7 Bil | |
VTRS
| Viatris Inc | Qcdrkflr | Lwg | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ztbfmldh | Ryrk | $11.9 Bil | |
CTLT
| Catalent Inc | Pwsbytbgp | Hncxyk | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Mcynxyrty | Flgn | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Ycyblgx | Qvdyw | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Tppgxbbm | Jyvfp | $3.5 Bil |